DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
LEVOMEPROMAZINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LEVOMEPROMAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
42BB1Y2586
Molecule Type:
Small molecule
Molecular Formula:
C19H25ClN2OS
Molecular Weight:
364.94
AlogP:
4.5
PSA:
15.71
HBD:
0.0
HBA:
#RotB:
5.0
Source:
DIBENZEPIN
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Histamine H1 receptor antagonist
DIBENZEPIN
×
Maximum Phase:
4
First Approval:
None
UNII:
510SJZ1Y6L
Molecule Type:
Small molecule
Molecular Formula:
C18H21N3O
Molecular Weight:
295.39
AlogP:
2.98
PSA:
26.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
MESTEROLONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MESTEROLONE
×
Maximum Phase:
4
First Approval:
None
UNII:
0SRQ75X9I9
Molecule Type:
Small molecule
Molecular Formula:
C20H32O2
Molecular Weight:
304.47
AlogP:
4.21
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
LOBEGLITAZONE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus, Type 2; Diabetes Mellitus
Unknown
LOBEGLITAZONE
×
Maximum Phase:
4
First Approval:
None
UNII:
MY89F08K5D
Molecule Type:
Small molecule
Molecular Formula:
C24H24N4O5S
Molecular Weight:
480.55
AlogP:
3.69
PSA:
102.88
HBD:
1.0
HBA:
#RotB:
10.0
Source:
CEFSULODIN
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial penicillin-binding protein inhibitor
CEFSULODIN
×
Maximum Phase:
4
First Approval:
None
UNII:
OV42LHE42B
Molecule Type:
Small molecule
Molecular Formula:
C22H20N4O8S2
Molecular Weight:
532.56
AlogP:
-0.9
PSA:
190.88
HBD:
3.0
HBA:
#RotB:
8.0
Source:
PRAJMALIUM
4
Small molecule
Approved
Unknown
Unknown
Arrhythmias, Cardiac
Unknown
PRAJMALIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
75934UD4GJ
Molecule Type:
Small molecule
Molecular Formula:
C23H33N2O2+
Molecular Weight:
369.53
AlogP:
2.48
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MALIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MALIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
817L1N4CKP
Molecule Type:
Small molecule
Molecular Formula:
C4H6O5
Molecular Weight:
134.09
AlogP:
-1.09
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
3.0
Source:
DURAPATITE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DURAPATITE
×
Maximum Phase:
4
First Approval:
None
UNII:
91D9GV0Z28
Molecule Type:
Small molecule
Molecular Formula:
HCa5O13P3
Molecular Weight:
502.31
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
EXIFONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
EXIFONE
×
Maximum Phase:
4
First Approval:
None
UNII:
38K9TOD4EG
Molecule Type:
Small molecule
Molecular Formula:
C13H10O7
Molecular Weight:
278.22
AlogP:
1.15
PSA:
138.45
HBD:
6.0
HBA:
#RotB:
2.0
Source:
NONOXYNOL-9
4
Small molecule
Approved
OTHER
VAGINAL
Unknown
Unknown
NONOXYNOL-9
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARTENIMOL
4
Small molecule
Approved
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Lupus Erythematosus, Systemic; Polycystic Ovary Syndrome; Fever; Malaria, Falciparum; Malaria, Vivax; Malaria
Ferriprotoporphyrin IX binding agent
ARTENIMOL
×
Maximum Phase:
4
First Approval:
None
UNII:
6A9O50735X
Molecule Type:
Small molecule
Molecular Formula:
C15H24O5
Molecular Weight:
284.35
AlogP:
2.19
PSA:
57.15
HBD:
1.0
HBA:
#RotB:
0.0
Source:
NIALAMIDE
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Monoamine oxidase inhibitor
NIALAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
T2Q0RYM725
Molecule Type:
Small molecule
Molecular Formula:
C16H18N4O2
Molecular Weight:
298.35
AlogP:
1.02
PSA:
83.12
HBD:
3.0
HBA:
#RotB:
7.0
Source:
ECABET
4
Small molecule
Approved
Unknown
Unknown
Dry Eye Syndromes
Unknown
ECABET
×
Maximum Phase:
4
First Approval:
None
UNII:
2K02669KWP
Molecule Type:
Small molecule
Molecular Formula:
C20H28O5S
Molecular Weight:
380.51
AlogP:
4.15
PSA:
91.67
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FLOXACILLIN
4
Small molecule
Approved
Unknown
Unknown
Infections; Renal Insufficiency, Chronic; Osteomyelitis; Cellulitis; Skin Diseases; Staphylococcal Infections; Bacterial Infections
Bacterial penicillin-binding protein inhibitor
FLOXACILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
43B2M34G2V
Molecule Type:
Small molecule
Molecular Formula:
C19H17ClFN3O5S
Molecular Weight:
453.88
AlogP:
2.69
PSA:
112.74
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CYSTINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CYSTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
48TCX9A1VT
Molecule Type:
Small molecule
Molecular Formula:
C6H12N2O4S2
Molecular Weight:
240.31
AlogP:
-0.81
PSA:
126.64
HBD:
4.0
HBA:
#RotB:
7.0
Source:
CHLORMERODRIN HG-197
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
CHLORMERODRIN HG-197
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BLONANSERIN
4
Small molecule
Approved
Unknown
Unknown
Schizophrenia
Dopamine D2 receptor antagonist
BLONANSERIN
×
Maximum Phase:
4
First Approval:
None
UNII:
AQ316B4F8C
Molecule Type:
Small molecule
Molecular Formula:
C23H30FN3
Molecular Weight:
367.51
AlogP:
4.69
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
3.0
Source:
GRISEOFULVIN, ULTRAMICROSIZE
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
GRISEOFULVIN, ULTRAMICROSIZE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CLOVE OIL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CLOVE OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
578389D6D0
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORMERODRIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CHLORMERODRIN
×
Maximum Phase:
4
First Approval:
None
UNII:
99T5TWO621
Molecule Type:
Small molecule
Molecular Formula:
C5H11ClHgN2O2
Molecular Weight:
367.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MEPHOBARBITAL
4
Small molecule
Approved
Unknown
Unknown
Epilepsy
Unknown
MEPHOBARBITAL
×
Maximum Phase:
4
First Approval:
None
UNII:
5NC67NU76B
Molecule Type:
Small molecule
Molecular Formula:
C13H14N2O3
Molecular Weight:
246.27
AlogP:
1.04
PSA:
66.48
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FLUSPIRILENE
4
Small molecule
Approved
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders
Dopamine D2 receptor inhibitor
FLUSPIRILENE
×
Maximum Phase:
4
First Approval:
None
UNII:
C5QA4GLR9M
Molecule Type:
Small molecule
Molecular Formula:
C29H31F2N3O
Molecular Weight:
475.58
AlogP:
5.31
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CLOTIAZEPAM
4
Small molecule
Approved
Unknown
Unknown
Anxiety
GABA-A receptor; anion channel positive allosteric modulator
CLOTIAZEPAM
×
Maximum Phase:
4
First Approval:
None
UNII:
ZCN055599V
Molecule Type:
Small molecule
Molecular Formula:
C16H15ClN2OS
Molecular Weight:
318.83
AlogP:
3.78
PSA:
32.67
HBD:
0.0
HBA:
#RotB:
2.0
Source:
KRX-0502
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
KRX-0502
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PADELIPORFIN
4
Small molecule
Approved
Unknown
Unknown
Kidney Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Prostatic Neoplasms, Castration-Resistant; Neoplasms
Unknown
PADELIPORFIN
×
Maximum Phase:
4
First Approval:
None
UNII:
EEO29FZT86
Molecule Type:
Small molecule
Molecular Formula:
C37H43N5O9PdS
Molecular Weight:
840.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TECHNETIUM TC-99M PENTETATE KIT
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M PENTETATE KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBENOXOLONE SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CARBENOXOLONE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
F1MP7242Z5
Molecule Type:
Small molecule
Molecular Formula:
C34H48Na2O7
Molecular Weight:
614.73
AlogP:
6.83
PSA:
117.97
HBD:
2.0
HBA:
#RotB:
5.0
Source:
POTASSIUM PHOSPHATE, MONOBASIC
4
Small molecule
Approved
Unknown
Unknown
Hypophosphatemia
Unknown
POTASSIUM PHOSPHATE, MONOBASIC
×
Maximum Phase:
4
First Approval:
None
UNII:
4J9FJ0HL51
Molecule Type:
Small molecule
Molecular Formula:
H2KO4P
Molecular Weight:
136.08
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CHOLINE ALFOSCERATE
4
Small molecule
Approved
Unknown
Unknown
Cognitive Dysfunction; Diabetes Mellitus, Type 2
Unknown
CHOLINE ALFOSCERATE
×
Maximum Phase:
4
First Approval:
None
UNII:
60M22SGW66
Molecule Type:
Small molecule
Molecular Formula:
C8H20NO6P
Molecular Weight:
257.22
AlogP:
-1.45
PSA:
99.05
HBD:
2.0
HBA:
#RotB:
8.0
Source:
CADEXOMER IODINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CADEXOMER IODINE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEGLUMINE
4
Small molecule
Approved
Unknown
Unknown
Acidosis; Ischemic Stroke; Leishmaniasis; Leishmaniasis, Mucocutaneous
Unknown
MEGLUMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
6HG8UB2MUY
Molecule Type:
Small molecule
Molecular Formula:
C7H17NO5
Molecular Weight:
195.22
AlogP:
-3.36
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
6.0
Source:
IPRINDOLE
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Unknown
IPRINDOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
69U0IKR8FP
Molecule Type:
Small molecule
Molecular Formula:
C19H28N2
Molecular Weight:
284.45
AlogP:
4.25
PSA:
8.17
HBD:
0.0
HBA:
#RotB:
4.0
Source:
SULFUR, PRECIPITATED
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SULFUR, PRECIPITATED
×
Maximum Phase:
4
First Approval:
None
UNII:
70FD1KFU70
Molecule Type:
Small molecule
Molecular Formula:
S
Molecular Weight:
32.07
AlogP:
0.65
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
AMOBARBITAL SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
AMOBARBITAL SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
G0313KNC7D
Molecule Type:
Small molecule
Molecular Formula:
C11H17N2NaO3
Molecular Weight:
248.26
AlogP:
1.39
PSA:
78.76
HBD:
2.0
HBA:
#RotB:
4.0
Source:
THIMEROSAL
4
Small molecule
Approved
Unknown
Unknown
Hepatitis B, Chronic
Antimicrobial preservative, used in vaccines
THIMEROSAL
×
Maximum Phase:
4
First Approval:
None
UNII:
2225PI3MOV
Molecule Type:
Small molecule
Molecular Formula:
C9H9HgNaO2S
Molecular Weight:
404.82
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
161
162
163
164
165
166
167
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA